Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cystic fibrosis modifying genes].

N Knauer1, F Ratjen, H Grasemann

  • 1Zentrum für Kinder- und Jugendmedizin, Abteilung für Allgemeine Pädiatrie, Universitätsklinikum Essen, Essen.

Pneumologie (Stuttgart, Germany)
|July 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary arteriovenous malformation in children.

Pediatric pulmonology·2024
Same author

SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
Same author

Infant spirometry as a predictor of lung function at early childhood in cystic fibrosis patients.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same author

Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020
Same author

Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung.

Nutrition & diabetes·2017
Same author

l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016

Cystic fibrosis (CF) is an autosomal recessive disease caused by CFTR gene mutations. This review explores genetic factors that modify CFTR mutations, influencing disease severity and identifying therapeutic targets.

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Science

Context:

  • Cystic fibrosis (CF) is a prevalent autosomal recessive genetic disorder.
  • It stems from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes a chloride ion channel.
  • CFTR gene mutations disrupt fluid and salt secretion, leading to diverse clinical manifestations.

Purpose:

  • To review association studies investigating genetic modifiers of cystic fibrosis.
  • To understand the genotype-phenotype correlations in CF, independent of CFTR mutations.
  • To identify novel therapeutic targets for CF treatment.

Summary:

  • This review synthesizes findings from studies examining genetic factors that influence cystic fibrosis (CF) disease progression.

Related Experiment Videos

  • It highlights that environmental and genetic elements, separate from the CFTR gene, significantly modulate the pulmonary aspects of CF.
  • The variability in CF phenotypes, even among individuals with identical CFTR mutations, underscores the role of these modifier genes.

    • Impact:

    • Elucidating the molecular basis of genotype-phenotype associations in CF.
    • Providing a foundation for developing targeted therapies to address CF heterogeneity.
    • Improving the understanding of disease mechanisms for better patient outcomes.